CoChat

A Randomized, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Rofecoxib in the Treatment of Chronic Nonbacterial Prostatitis

NICKEL, J. CURTIS, PONTARI, MICHEL, MOON, TIMOTHY, GITTELMAN, MARC, MALEK, GHOLAM, FARRINGTON, JEAN, PEARSON, JAY, KRUPA, DAVID, BACH, MARK, DRISKO, JENNIFER, THE ROFECOXIB PROSTATITIS INVESTIGATOR TEAM · 2003 · Journal of Urology
Cited by 120

The DOI matches its Crossref record.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.ju.0000054983.45096.16

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 19

  1. McNaughton Collins, 1998, How common is prostatitis? A national survey of physician visits, J Urol, 159, 1224, 10.1016/S0022-5347(01)63564-X · DOI · Paper page
  2. Mehik, 2000, Epidemiology of prostatitis in Finnish men: a population-based cross-sectional study, BJU Int, 86, 443, 10.1046/j.1464-410X.2000.00836.x · DOI · Paper page
  3. Nickel, 2001, Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index, J Urol, 165, 842, 10.1016/S0022-5347(05)66541-X · DOI · Paper page
  4. Krieger, 1999, NIH consensus definition and classification of prostatitis, JAMA, 282, 236, 10.1001/jama.282.3.236 · DOI · Paper page
  5. Nickel, 1999, Prostatitis: evolving management strategies, Urol Clin North Am, 26, 737, 10.1016/S0094-0143(05)70215-9 · doi:10.1016/s0094-0143(05)70215-9
  6. O'Leary, 2001, Are there long term changes in symptoms over time in men with chronic prostatitis? An interim report from the Chronic Prostatitis Cohort (CPC) study, J Urol, 165, 24
  7. Nickel, 2001, The natural history of prostatitis-like symptoms: a population based study, J Urol, 165, 23
  8. McNaughton Collins, 2000, Diagnosis and treatment of chronic abacterial prostatitis: a systematic review, Ann Intern Med, 133, 367, 10.7326/0003-4819-133-5-200009050-00013 · DOI
  9. Donnelly, 1997, Review article: COX-II inhibitors—a new generation of safer NSAIDS?, Aliment Pharmacol Ther, 11, 227, 10.1046/j.1365-2036.1997.154330000.x · DOI
  10. Alexander, 1998, Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syndrome, Urology, 52, 744, 10.1016/S0090-4295(98)00390-2 · DOI · Paper page
  11. Spaziani, 1996, The induction of cyclooxygenase-2 (COX-2) in intact human amnion tissue by interleukin-4, Prostaglandins, 51, 215, 10.1016/0090-6980(96)00005-6 · DOI
  12. Benaim, 2001, Correlation between the histological grade and COX-2 expression in prostate cancer, J Urol, 165, 240
  13. Madaan, 2000, Cytoplasmic induction and over-expression of cyclooxygenase-2 in human prostate cancer: implications for prevention and treatment, BJU Int, 86, 736, 10.1046/j.1464-410x.2000.00867.x · DOI · Paper page
  14. Propert, 2002, Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome, Urology, 59, 870, 10.1016/S0090-4295(02)01601-1 · doi:10.1016/s0090-4295(02)01601-1
  15. Meares, 1968, Bacteriologic localization patterns in bacterial prostatitis and urethritis, Invest Urol, 5, 492
  16. Litwin, 1999, The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure, J Urol, 162, 369, 10.1016/S0022-5347(05)68562-X · DOI · Paper page
  17. Bellamy, 1997, Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand oseoarthritis. Consensus development at OMERACT III, J Rheumatol, 24, 799
  18. Barry, 1995, Measuring disease-specific health status in men with benign prostatic hyperplasia. Measurement Committee of the American Urological Association, Med Care, 33, AS145
  19. Schaeffer, 2002, Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: The National Institutes of Health Chronic Prostatitis Cohort Study, J Urol, 168, 1048, 10.1016/S0022-5347(05)64572-7 · DOI · Paper page

Cited by

See all 120

Metadata

Authors
NICKEL, J. C., PONTARI, M., MOON, T., GITTELMAN, M., MALEK, G., FARRINGTON, J., PEARSON, J., KRUPA, D., BACH, M., DRISKO, J., & THE ROFECOXIB PROSTATITIS INVESTIGATOR TEAM
Affiliations
From the Department of Urology, Queen’s University, Kingston General Hospital, Kingston, Ontario, Canada, the Department of Urology, Temple University School of Medicine, Philadelphia, Pennsylvania, University of Wisconsin Medical School and Jackson Foundation, Madison, Wisconsin, South Florida Medical Center, Aventura, Florida, and Merck Research Laboratories, Rahway, New Jersey
Venue
Journal of Urology
Published
2003-04
Volume
169
Issue
4
Pages
1401-1405
ISSN
  • 0022-5347
  • 1527-3792
Cited by
120
References
0
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Randomized, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Rofecoxib in the Treatment of Chronic Nonbacterial Prostatitis. https://app.cochat.ai/papers/10.1097/01.ju.0000054983.45096.16
The paper
NICKEL, J. C., PONTARI, M., MOON, T., GITTELMAN, M., MALEK, G., FARRINGTON, J., PEARSON, J., KRUPA, D., BACH, M., DRISKO, J., & THE ROFECOXIB PROSTATITIS INVESTIGATOR TEAM. (2003). A Randomized, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Rofecoxib in the Treatment of Chronic Nonbacterial Prostatitis. Journal of Urology. https://doi.org/10.1097/01.ju.0000054983.45096.16

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.